LONDON – Optima Health plc (AIM: OPT), the UK's leading provider of health and wellbeing solutions to businesses, has revealed a recent deal involving a key insider. Joan Newey, who is Group Business Development and Propositions Director and PDMR within the company, purchased 14,046 ordinary shares at a price of 143.14p per share on 17 January 2025.
This transaction was completed on London Stock Exchange (LON:) on the AIM market, following this acquisition, Newey now owns a total of 84,080 common shares. Its share represents approximately 0.09% of the current issued share capital of Optima Health.
Optima Health has been a prominent player in the occupational health and wellbeing sector for 25 years, providing innovative and tailored solutions to a diverse range of clients. The company emphasizes the importance of a healthy, high-performance workplace, and leverages its clinical expertise to effectively meet the needs of its clients.
The announcement of this insider purchase is a routine disclosure required by market regulations, and is intended to maintain transparency in the financial activities involving company insiders. These disclosures provide investors and the market with insight into the actions of those with management responsibilities within publicly traded companies.
This information is based on a press release issued by Optima Health plc.
This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.
